Nimotuzumab Combined With Sintilimab and Chemotherapy for Advanced Esophageal Squamous Cell Carcinoma

NCT06718205 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

112

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Cancer

Interventions

DRUG: Nimotuzumab
DRUG: Sintilimab
DRUG: Paclitaxel-albumin
DRUG: Cisplatin

Sponsor

The First Affiliated Hospital of Zhengzhou University